Yoshitaka Sekido

10PUBLICATIONS
44CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 28, 2026
VISTA drives tumour-intrinsic proliferation in mesothelioma cells.

|May 02, 2026
BAP1 and USP1 cooperate to regulate FANCD2 stability and cell proliferation in mesothelioma cells.

|Mar 06, 2026
Enhanced nuclear export caused by O-GlcNAcylation of nucleoporins is a potential therapeutic target in mesothelioma.

Satomi Mukai, Tatsuhiro Sato, Yasuhiro Kamei

|Aug 07, 2025
Pleural mesothelioma.

Dean A Fennell, Yoshitaka Sekido, Paul Baas

|Dec 17, 2024
TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.

Ken Akao, Tatsuhiro Sato, Emi Mishiro-Sato

|Oct 06, 2023
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.

Soichi Hirai, Tadaaki Yamada, Yuki Katayama

Pageof 2

Frequent Collaborators

3 joint publications

Satomi Mukai

3 joint publications

Emi Mishiro-Sato

3 joint publications

Tatsuhiro Sato

2 joint publications

Yuko Murakami-Tonami